Andrew O'Connor currently serves as a Board Observer for multiple companies including Daqus Energy, Elementium Materials, Inc., Robigo, and kea, while also holding the position of Board Member at OptoGlo Solar Signs. In addition, Andrew O'Connor is the Chairman of the Board at NanoPath, a role that emphasizes leadership in strategic decision-making. Since September 2022, Andrew O'Connor has been an Investment Professional at Morningside Technology Advisory LLC, focusing on partnerships with innovative founders. Prior experience includes serving as COO for Alveolus Bio, a company specializing in chronic and infectious pulmonary disease treatments, and for ResBiotic, which produces health-oriented probiotics. Andrew O'Connor's academic credentials include an MBA from Harvard Business School, an MS in Engineering Sciences from Harvard John A. Paulson School, and a Bachelor of Chemical Engineering from Auburn University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices